Free Trial
→ Is SpaceX really worth 1.78 Trillion? (From InvestPub) (Ad)tc pixel Free AGRX Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Agile Therapeutics (AGRX) Short Interest Ratio & Short Volume

Agile Therapeutics logo
Compare

Agile Therapeutics Short Interest Overview

As of March 15, 2024, Agile Therapeutics (AGRX) had a short interest of 361,300 shares sold short, representing 12.68% of the public float. This marks a 62.67% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.5, meaning it would take 0.5 days of the average trading volume of 352,864 shares to cover all short positions.

Current Short Interest
361,300 shares
Previous Short Interest
222,100 shares
Change Vs. Previous Month
62.67%
Dollar Volume Sold Short
$196.19 thousand
Short Interest Ratio
0.5 Days to Cover
Last Record Date
March 15, 2024
Outstanding Shares
6,856,000 shares
Float Size
2,850,000 shares
Short Percent of Float
12.68%
Today's Trading Volume
0 shares
Average Trading Volume
352,864 shares
Today's Volume Vs. Average
0%
Short Selling Agile Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Agile Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AGRX Short Interest Over Time

AGRX Days to Cover Over Time

AGRX Percentage of Float Shorted Over Time

Agile Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2024361,300 shares $196.19 thousand +62.7%12.7%0.5 $0.54
2/29/2024222,100 shares $176.57 thousand +4.2%7.9%0.6 $0.80
2/15/2024213,100 shares $260.49 thousand +12.2%7.5%0.6 $1.22
1/31/2024189,900 shares $290.55 thousand +129.9%6.7%2.8 $1.53
1/15/202482,600 shares $154.46 thousand +287.8%3.4%1.3 $1.87
12/31/202321,300 shares $41.54 thousand +156.6%0.9%0.4 $1.95
12/15/20238,300 shares $16.77 thousand +23.9%0.4%0.2 $2.02
11/30/20236,700 shares $13.87 thousand -62.8%0.3%0.2 $2.07
11/15/202318,000 shares $40.14 thousand +12.5%0.8%0.4 $2.23
10/31/202316,000 shares $28.96 thousand +263.6%0.9%0.4 $1.81
10/15/20234,400 shares $7.83 thousand -76.5%0.2%0.1 $1.78
9/30/202318,700 shares $44.88 thousand +567.9%1.0%0.4 $2.40
9/15/20232,800 shares $5.85 thousand -73.8%0.2%0.1 $2.09
8/31/202310,700 shares $27.82 thousand -48.3%0.6%0.1 $2.60
8/15/202320,700 shares $45.13 thousand -46.2%1.1%0.2 $2.18
7/31/202338,500 shares $111.65 thousand -45.8%1.4%0.3 $2.90
7/15/202371,000 shares $202.35 thousand -42.5%2.5%0.6 $2.85
6/30/2023123,400 shares $364.03 thousand -36.7%4.4%1.1 $2.95
6/15/2023194,800 shares $633.10 thousand +146.3%6.7%1.9 $3.25
5/31/202379,100 shares $299.79 thousand +16.5%2.7%2.8 $3.79
5/15/202367,900 shares $322.53 thousand +46.0%6.9%2.6 $4.75
4/30/202346,500 shares $299.93 thousand +37.6%5.3%2.4 $6.45
4/15/202333,800 shares $235.92 thousand +350.7%3.8%1.8 $6.98
3/31/20237,500 shares $1.68 thousand -96.7%0.9%0.4 $0.22
3/15/2023225,700 shares $48.82 thousand -39.7%0.6%0.3 $0.22
2/28/2023374,400 shares $89.82 thousand -28.7%1.0%0.5 $0.24
2/15/2023524,900 shares $152.22 thousand -25.0%1.3%0.7 $0.29
1/31/2023699,500 shares $188.87 thousand +2.5%1.8%0.8 $0.27
1/15/2023682,600 shares $197.95 thousand -0.1%1.7%0.8 $0.29
12/30/2022683,200 shares $155.09 thousand -0.1%1.7%0.8 $0.23
12/15/2022684,100 shares $132.72 thousand -18.7%1.7%0.8 $0.19
11/30/2022841,200 shares $176.65 thousand -22.8%2.1%0.8 $0.21
11/15/20221,090,000 shares $253.21 thousand -31.0%2.8%0.9 $0.23
10/31/20221,580,000 shares $440.82 thousand +29.5%4.2%0.8 $0.28
10/15/20221,220,000 shares $318.79 thousand -2.4%3.2%0.5 $0.26
9/30/20221,250,000 shares $371.13 thousand -15.0%3.3%0.3 $0.30
9/15/20221,470,000 shares $588 thousand -6.4%3.9%0.1 $0.40
8/31/20221,570,000 shares $631.93 thousand -19.5%4.1%0.1 $0.40
8/15/20221,950,000 shares $1.05 million +42.3%5.1%0.2 $0.54
7/31/20221,370,000 shares $699.93 thousand +77.4%3.6%0.1 $0.51
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Harvard MBA, former hedge fund manager, and 30-year Wall Street veteran - calls these the most overhyped, overvalued large-cap stocks ever brought to market. Tilson believes a rare economic event is forming, one he says could reset the financial system in ways most investors aren't prepared for. He's put together a free analysis outlining exactly what he sees and the steps he recommends taking with your money now.tc pixel

Read Whitney Tilson's free analysis and find out what to do instead
7/15/2022772,200 shares $427.03 thousand -73.7%2.0%0.1 $0.55
6/30/20222,940,000 shares $3.43 million +510.5%7.8%0.3 $1.17
6/15/2022481,600 shares $587.55 thousand -4.2%10.9%1 $1.22
5/31/2022502,600 shares $703.64 thousand +126.7%11.4%1.2 $1.40
5/15/2022221,700 shares $361.37 thousand -22.7%5.0%0.6 $1.63
4/30/2022286,900 shares $657.00 thousand -88.5%N/A0.9 $2.29
4/15/20222,500,000 shares $407.50 thousand +95.3%N/A0.3 $0.16
3/31/20221,280,000 shares $268.16 thousand -33.0%N/A0.7 $0.21
3/15/20221,910,000 shares $458.59 thousand +34.5%N/A1.7 $0.24
2/28/20221,420,000 shares $434.52 thousand +2.2%N/A1.2 $0.31
2/15/20221,390,000 shares $463.57 thousand -14.2%N/A1 $0.33
1/31/20221,620,000 shares $565.38 thousand -28.6%N/A1.1 $0.35
1/15/20222,270,000 shares $862.60 thousand -7.7%N/A1.5 $0.38
12/31/20212,460,000 shares $1.20 million +2.1%N/A1.2 $0.49
12/15/20212,410,000 shares $1.41 million +54.5%N/A1.1 $0.58
11/30/20211,560,000 shares $982.80 thousand +8.3%N/A0.8 $0.63
11/15/20211,440,000 shares $1.07 million -11.7%N/A0.8 $0.75
10/29/20211,630,000 shares $1.29 million +14.0%N/A1 $0.79
10/15/20211,430,000 shares $1.09 million -42.6%N/A0.9 $0.76
9/30/20212,490,000 shares $2.39 million +1.2%3.0%2.5 $0.96
9/15/20212,460,000 shares $2.61 million -7.5%2.9%2.9 $1.06
8/31/20212,660,000 shares $3.09 million +13.2%3.2%3 $1.16
8/13/20212,350,000 shares $2.42 million -4.9%2.8%2.6 $1.03
7/30/20212,470,000 shares $2.96 million +1.7%3.0%2.6 $1.20
7/15/20212,430,000 shares $2.99 million -12.6%3.1%2.4 $1.23
6/30/20212,780,000 shares $3.70 million -57.1%3.5%2.6 $1.33
6/15/20216,480,000 shares $9.85 million +3.4%8.2%6.4 $1.52

AGRX Short Interest - Frequently Asked Questions

Short interest is the volume of Agile Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 361,300 shares of AGRX short. 12.68% of Agile Therapeutics' shares are currently sold short. Learn More on Agile Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGRX shares currently have a short interest ratio of 0.5. Learn More on Agile Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.68% of Agile Therapeutics' floating shares are currently sold short.

Agile Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 361,300 shares, an increase of 62.7% from the previous total of 222,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Agile Therapeutics currently has issued a total of 6,856,000 shares. Some of Agile Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Agile Therapeutics currently has a public float of 2,850,000 shares.

12.68% of Agile Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Agile Therapeutics: MIRA Pharmaceuticals, Inc. (0.94%), Gossamer Bio, Inc. (28.84%), Entero Therapeutics, Inc. (1.11%), RenovoRx, Inc. (1.02%), Hyperion DeFi, Inc. (5.49%), Alterity Therapeutics Limited - Sponsored ADR (0.17%), BGM Group Ltd. (0.63%), Grace Therapeutics, Inc. (14.65%), BioXcel Therapeutics, Inc. (11.86%), Greenland Mines Ltd. Common Stock (6.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors Company ($3.36 billion), Occidental Petroleum Corporation ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply Company ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks.

Short selling AGRX is an investing strategy that aims to generate trading profit from Agile Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Agile Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGRX, twice per month. The most recent reporting period available is March, 15 2024.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AGRX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:AGRX) was last updated on 6/14/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
This Could Be the Biggest Monetary Shift in 50 Years
Tucked inside U.S. Code Title 31, Section 5117 is a provision allowing the Treasury to reprice America's gold ...
Americas Gold Company | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Ha...
Stansberry Research | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Read this warning immediately
Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the bigg...
Porter & Company | Sponsoredtc pixel